117 related articles for article (PubMed ID: 15039280)
1. A recombinant murine meizothrombin precursor, prothrombin R157A/R268A, inhibits thrombosis in a model of acute carotid artery injury.
Shim K; Zhu H; Westfield LA; Sadler JE
Blood; 2004 Jul; 104(2):415-9. PubMed ID: 15039280
[TBL] [Abstract][Full Text] [Related]
2. Multiple active forms of thrombin. IV. Relative activities of meizothrombins.
Doyle MF; Mann KG
J Biol Chem; 1990 Jun; 265(18):10693-701. PubMed ID: 2355015
[TBL] [Abstract][Full Text] [Related]
3. Mutations in autolytic loop-2 and at Asp554 of human prothrombin that enhance protein C activation by meizothrombin.
Koike H; Okuda D; Morita T
J Biol Chem; 2003 Apr; 278(17):15015-22. PubMed ID: 12588872
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of recombinant human meizothrombin and Meizothrombin(desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition.
Côté HC; Bajzar L; Stevens WK; Samis JA; Morser J; MacGillivray RT; Nesheim ME
J Biol Chem; 1997 Mar; 272(10):6194-200. PubMed ID: 9045633
[TBL] [Abstract][Full Text] [Related]
5. Binding of hirudin to meizothrombin.
Fischer BE; Schlokat U; Himmelspach M; Dorner F
Protein Eng; 1998 Aug; 11(8):715-21. PubMed ID: 9749925
[TBL] [Abstract][Full Text] [Related]
6. Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice.
Shaw MA; Kombrinck KW; McElhinney KE; Sweet DR; Flick MJ; Palumbo JS; Cheng M; Esmon NL; Esmon CT; Brill A; Wagner DD; Degen JL; Mullins ES
Blood; 2016 Aug; 128(5):721-31. PubMed ID: 27252233
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of meizothrombin and meizothrombin(desF1) by heparin cofactor II.
Han JH; Côté HC; Tollefsen DM
J Biol Chem; 1997 Nov; 272(45):28660-5. PubMed ID: 9353333
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin-resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation.
Takagi Y; Kato I; Ando Y; Nakamura Y; Murata M; Takagi A; Murate T; Kojima T
Thromb Res; 2014 Oct; 134(4):914-7. PubMed ID: 25149909
[TBL] [Abstract][Full Text] [Related]
9. Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin.
Hackeng TM; Tans G; Koppelman SJ; de Groot PG; Rosing J; Bouma BN
Biochem J; 1996 Oct; 319 ( Pt 2)(Pt 2):399-405. PubMed ID: 8912673
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A).
Côté HC; Stevens WK; Bajzar L; Banfield DK; Nesheim ME; MacGillivray RT
J Biol Chem; 1994 Apr; 269(15):11374-80. PubMed ID: 8157669
[TBL] [Abstract][Full Text] [Related]
11. Ligand specificity of human thrombomodulin. Equilibrium binding of human thrombin, meizothrombin, and factor Xa to recombinant thrombomodulin.
Wu Q; Tsiang M; Lentz SR; Sadler JE
J Biol Chem; 1992 Apr; 267(10):7083-8. PubMed ID: 1313033
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the anticoagulant profile of meizothrombin.
Stojanovski BM; Pelc LA; Zuo X; Pozzi N; Cera ED
Biomol Concepts; 2018 Dec; 9(1):169-175. PubMed ID: 30864392
[TBL] [Abstract][Full Text] [Related]
13. Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin.
Wu QY; Sheehan JP; Tsiang M; Lentz SR; Birktoft JJ; Sadler JE
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6775-9. PubMed ID: 1650482
[TBL] [Abstract][Full Text] [Related]
14. Activation of human factor V by meizothrombin.
Tans G; Nicolaes GA; Thomassen MC; Hemker HC; van Zonneveld AJ; Pannekoek H; Rosing J
J Biol Chem; 1994 Jun; 269(23):15969-72. PubMed ID: 8206891
[TBL] [Abstract][Full Text] [Related]
15. Na+ binding to meizothrombin desF1.
Papaconstantinou ME; Gandhi PS; Chen Z; Bah A; Di Cera E
Cell Mol Life Sci; 2008 Nov; 65(22):3688-97. PubMed ID: 18854941
[TBL] [Abstract][Full Text] [Related]
16. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation.
Rosing J; Zwaal RF; Tans G
J Biol Chem; 1986 Mar; 261(9):4224-8. PubMed ID: 3753979
[TBL] [Abstract][Full Text] [Related]
17. A novel congenital dysprothrombinemia leading to defective prothrombin maturation.
Bafunno V; Bury L; Tiscia GL; Fierro T; Favuzzi G; Caliandro R; Sessa F; Grandone E; Margaglione M; Gresele P
Thromb Res; 2014 Nov; 134(5):1135-41. PubMed ID: 25242243
[TBL] [Abstract][Full Text] [Related]
18. Autocatalytic peptide bond cleavages in prothrombin and meizothrombin.
Petrovan RJ; Govers-Riemslag JW; Nowak G; Hemker HC; Tans G; Rosing J
Biochemistry; 1998 Feb; 37(5):1185-91. PubMed ID: 9477942
[TBL] [Abstract][Full Text] [Related]
19. Activation of prothrombin by two subtilisin-like serine proteases from Acremonium sp.
Liu C; Matsushita Y; Shimizu K; Makimura K; Hasumi K
Biochem Biophys Res Commun; 2007 Jun; 358(1):356-62. PubMed ID: 17482570
[TBL] [Abstract][Full Text] [Related]
20. Meizothrombin is an unexpectedly zymogen-like variant of thrombin.
Bradford HN; Krishnaswamy S
J Biol Chem; 2012 Aug; 287(36):30414-25. PubMed ID: 22815477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
